Drug Response Profiling at KIYATEC

Complex Co-Culture Model Development

Learn about the world’s most advanced ex vivo immuno-oncology models.

Drug Response Profiling Services

3D cell culture service offerings & in vitro model development

Predicting Clinical Response

Learn more about our clinically relevant, predictive 3D response assays

KIYATEC Brochures & Posters

Recent News

KIYATEC Adds Oregon Health & Science University to Study to Predict Response to Cancer Therapy Prior to Treatment

Tags : 

GREENVILLE, SC. – February 6, 2019 – KIYATEC, Inc., today announced that Oregon Health & Science University (OHSU) Knight Cancer Institute has initiated patient enrollment into KIYATEC’s clinical study, 3D-PREDICT, to validate the company’s test as a patient-specific predictor of response to cancer therapies for solid tumors. In this clinical study, the test analyzes a

Read More

KIYATEC Strengthens Leadership Team with Appointment of Vice Presidents of Clinical Affairs and Commercial Operations

Tags : 

Company’s growth supports upcoming clinical programs to help better predict patient response to oncology drugs before treatment begins…

Read More

Telling Cancer to Take a Hike

Tags : 

Innovation milestone is a message of authentic hope for local cancer patients By Matthew Gevaert, Ph.D., and W. Jeffrey Edenfield, MD Cancer innovation and hiking the Appalachian Trail have a few things in common. Neither happens overnight; the AT typically takes five to seven months, and meaningful innovation in cancer research can take five to

Read More

GHS and KIYATEC Announcement Video

Tags : 

Greenville Health System and Kiyatec Research announced exciting news about cancer care and treatment today.

Read More

Learn More About KIYATEC